A Guide to Lung Cancer Care Pathways in Singapore

 

Lung cancer is one of the leading causes of cancer-related deaths in Singapore and globally. Despite advancements in medical technology, the disease often presents at an advanced stage due to a lack of early symptoms. However, Singapore’s healthcare system provides a structured and multi-layered approach to lung cancer care, involving early detection, diagnosis, multidisciplinary treatment planning, and ongoing support. This article outlines the key stages in the lung cancer care pathway in Singapore.

Early Detection and Diagnosis

Early detection significantly improves the chances of successful treatment. In Singapore, lung cancer screening is typically recommended for high-risk individuals—especially long-term smokers aged 55 and above, or those with a significant history of exposure to risk factors such as secondhand smoke or occupational carcinogens.

Low-dose computed tomography (LDCT) is the preferred screening tool, capable of identifying small nodules before symptoms appear. If a suspicious lesion is found, further diagnostic steps such as biopsy, bronchoscopy, or PET-CT scans may be used to determine the nature and extent of the disease.

Types and Staging

Lung cancer is broadly classified into two main types:

·         Non-Small Cell Lung Cancer (NSCLC): The most common form, accounting for about 85% of cases.

·         Small Cell Lung Cancer (SCLC): A more aggressive type that spreads quickly.

Accurate staging is essential for determining the appropriate treatment plan. Staging involves assessing the size of the tumor, lymph node involvement, and whether the cancer has spread to other organs. Singapore's hospitals typically follow the TNM (Tumor, Node, Metastasis) staging system and may use additional molecular testing to identify specific mutations (e.g., EGFR, ALK) that can inform targeted therapies.

 

Multidisciplinary Treatment Planning

Once a diagnosis is confirmed, a multidisciplinary team (MDT) of specialists—including medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, and pathologists—reviews the patient’s condition and formulates a personalised treatment plan.

This team-based approach is standard in both public institutions such as the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute (NCIS), as well as private hospitals across the country.

Treatment Modalities

The choice of treatment depends on the type, stage, and molecular profile of the cancer, as well as the patient’s overall health and preferences. Common treatment options include:

1. Surgery

Surgery may be an option for early-stage NSCLC and involves removing the tumor and part of the lung (lobectomy or pneumonectomy). Minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) are increasingly used.

2. Radiation Therapy

Radiation therapy is often used for patients who are not suitable for surgery or in combination with chemotherapy for locally advanced disease. Techniques such as stereotactic body radiation therapy (SBRT) allow precise targeting of tumors.

3. Chemotherapy

Chemotherapy is used across various stages, either alone or in combination with surgery or radiation. It’s especially common for SCLC, which tends to respond well to systemic treatment.

4. Targeted Therapy

Patients with specific genetic mutations (e.g., EGFR, ALK, ROS1) may benefit from targeted drugs that interfere with cancer cell growth. These therapies are available in Singapore and often cause fewer side effects than traditional chemotherapy.

5. Immunotherapy

Immunotherapy drugs, such as immune checkpoint inhibitors, help the body’s immune system recognize and attack cancer cells. These are generally used for advanced NSCLC and may be combined with chemotherapy.

Supportive and Palliative Care

Throughout the treatment journey, supportive care is critical in managing symptoms, side effects, and overall well-being. Services may include:

·         Pain management

·         Nutritional counseling

·         Respiratory therapy

·         Psychological support

·         Palliative care for advanced cases

Hospitals and cancer centres in Singapore offer integrated support programs that involve both medical and allied health professionals.

Access to Care

Lung cancer care is available in both public and private sectors. Public hospitals offer subsidised rates for eligible patients through schemes like MediSave, MediShield Life, and government assistance programs. Private care is also widely available and often chosen for faster access and customised care.

Conclusion

Singapore provides a structured and well-resourced pathway for lung cancer care—from early detection and diagnosis to advanced therapies and supportive services. The multidisciplinary approach ensures that patients receive comprehensive care tailored to their specific condition. As research advances and awareness grows, continued improvements in early screening and treatment options offer hope for better outcomes for those affected by lung cancer.

 

Comments

Popular posts from this blog

The Critical Link: How Early Liver Cancer Diagnosis Influences Curative Treatment Outcomes in Singapore

Breast Cancer Surgery vs. Breast-Conserving Approaches: Key Differences Explained

How Breast Cancer Treatment in Singapore Works and What to Know